Tranylcypromine in mind (Part II): Review of clinical pharmacology and meta-analysis of controlled studies in depression

@article{Ricken2017TranylcypromineIM,
  title={Tranylcypromine in mind (Part II): Review of clinical pharmacology and meta-analysis of controlled studies in depression},
  author={R. Ricken and S. Ulrich and P. Schlattmann and M. Adli},
  journal={European Neuropsychopharmacology},
  year={2017},
  volume={27},
  pages={714-731}
}
  • R. Ricken, S. Ulrich, +1 author M. Adli
  • Published 2017
  • Psychology, Medicine
  • European Neuropsychopharmacology
  • It has been over 50 years since a review has focused exclusively on the monoamine oxidase (MAO) inhibitor tranylcypromine (TCP). A new review has therefore been conducted for TCP in two parts which are written to be read preferably in close conjunction: part I - pharmacodynamics, pharmacokinetics, drug interactions, toxicology; and part II - clinical studies with meta-analysis of controlled studies in depression, practice of TCP treatment, place in therapy. The irreversible and nonselective MAO… CONTINUE READING
    13 Citations
    Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases
    • M. Youdim
    • Chemistry, Medicine
    • Journal of Neural Transmission
    • 2018
    • 29
    A reassessment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine myths
    • P. Gillman
    • Psychology, Medicine
    • Journal of Neural Transmission
    • 2018
    • 9
    Antidepressant Medications and Weight Change: A Narrative Review
    LSD1/KDM1A inhibitors in clinical trials: advances and prospects
    • 35
    The timeline of epigenetic drug discovery: from reality to dreams
    • 45
    • PDF

    References

    SHOWING 1-10 OF 168 REFERENCES
    Tranylcypromine: A review
    • 50
    Tranylcypromine vs nortriptyline vs placebo in depressed outpatients: a controlled trial
    • 17
    • Highly Influential
    Efficacy of Tranylcypromine in Bipolar Depression: A Systematic Review
    • 14
    MAOIs in the Contemporary Treatment of Depression
    • 213
    • PDF
    Brofaromine in non-endogenous major depressed inpatients--results of a preliminary dose-finding trial versus tranylcypromine.
    • 8
    • Highly Influential
    Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients.
    • 34
    • Highly Influential
    Revisiting the effectiveness of standard antidepressants in bipolar disorder: are monoamine oxidase inhibitors superior?
    • 27
    • Highly Influential
    • PDF
    Combined MAO-inhibitor and tri- (tetra) cyclic antidepressant treatment in therapy resistant depression
    • 29
    Double-blind comparison of moclobemide and tranylcypromine in depression.
    • 12